- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.06. | Catheter Precision, Inc. Forms new Joint Venture Called Kardionav to Exploit patented AI Techniques to Create New VT Software platform | 118 | GlobeNewswire (Europe) | FORT MILL, S.C., June 30, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
| 26.06. | Catheter Precision, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 12.06. | Catheter Precision, Inc. Comments on Recent Market Activity | 99 | GlobeNewswire (Europe) | FORT MILL, S.C., June 12, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, is issuing... ► Artikel lesen | |
| 12.06. | Catheter Precision, Inc.: Catheter Precision (VTAK) Reports Key Progress for the LockeT Product | 4 | GlobeNewswire (USA) | ||
| 09.06. | Catheter Precision, Inc. Secures VIVO Purchase Order From Sahlgrenska University Hospital | 1 | GlobeNewswire (USA) | ||
| 09.06. | Catheter Precision gibt Aktienoptionsschein an Ladenburg Thalmann aus | 2 | Investing.com Deutsch | ||
| 06.06. | Catheter Precision, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 30.05. | Catheter Precision, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| CATHETER PRECISION Aktie jetzt für 0€ handeln | |||||
| 27.05. | Catheter Precision Inc.: Catheter Precision, Inc. Receives CE Mark for LockeT | 1 | GlobeNewswire (USA) | ||
| 19.05. | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 14.05. | Catheter Precision reports Q1 results | 3 | Seeking Alpha | ||
| 14.05. | Catheter Precision, Inc. Announces First Quarter 2025 Update and Financial Results | 1.108 | GlobeNewswire (Europe) | FORT MILL, S.C., May 14, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced... ► Artikel lesen | |
| 13.05. | Catheter Precision raises $1.5M via private placement | 2 | Seeking Alpha | ||
| 13.05. | Catheter Precision, Inc. Announces $1.5 Million Private Placement Equity Financing and Potential Strategic Alliance | 5 | GlobeNewswire (USA) | ||
| 08.05. | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.04. | Catheter Precision to acquire late-stage heart failure treatment assets in development | 1 | Seeking Alpha | ||
| 17.04. | Catheter Precision, Inc.: Catheter Precision Makes NYSE American Section 610(b) Public Announcement | 1 | GlobeNewswire (USA) | ||
| 16.04. | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 01.04. | Catheter Precision, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 28.03. | Catheter Precision, Inc. Announces Fourth Quarter and Full Year 2024 Update and Financial Results | 311 | GlobeNewswire (Europe) | FORT MILL, S.C., March 28, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced... ► Artikel lesen |
1 2 3 Weiter >>
47 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 40,760 | -0,32 % | Aktie von Fresenius SE & Co. KGaA heute am Aktienmarkt kaum gefragt: Kurs fällt (41,21 €) | An der deutschen Börse notiert die Fresenius SE & Co. KGaA-Aktie derzeit ein wenig leichter. Die Aktie notiert zur Stunde bei 41,21 Euro. Der Anteilsschein von Fresenius+Co KgaA verzeichnet aktuell... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 45,230 | -1,55 % | DAX tiefer, Bitcoin, Silber stark: BASF, Lufthansa, BMW, Rheinmetall, FMC, Siemens Energy ... | Die Ankündigung von Donald Trump, Importe aus der EU ab 1. August mit einem Zoll in Höhe von 30 Prozent belegen zu wollen, hat beim DAX am Freitag Bremsspuren hinterlassen. Der deutsche Leitindex verabschiedete... ► Artikel lesen | |
| ECKERT & ZIEGLER | 66,25 | -1,56 % | EQS-News: Eckert & Ziegler SE: Ausbildungsqualität erneut ausgezeichnet | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Sonstiges
Eckert & Ziegler: Ausbildungsqualität erneut ausgezeichnet
15.07.2025 / 14:00 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen | |
| BICO GROUP | 3,144 | -1,38 % | UNGLAUBLICHE Sondermeldung bei Bico Group Aktie: DAS erwischt Anleger heute eiskalt. Dringend lesen und reagieren! | ||
| SERNOVA BIOTHERAPEUTICS | 0,105 | +1,94 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
| CARDINAL HEALTH | 136,55 | -0,51 % | Cardinal Health Launches One Voice Initiative To Empower Pharmacy Advocacy | WASHINGTON (dpa-AFX) - Cardinal Health (CAH) has introduced the Cardinal Health One Voice Initiative, a new program designed to financially support state pharmacy associations in bolstering... ► Artikel lesen | |
| RESMED | 223,50 | +0,72 % | Analyst Expectations For ResMed's Future | ||
| ATOSSA THERAPEUTICS | 0,720 | -0,55 % | Atossa Therapeutics, Inc.: Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22 | SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines... ► Artikel lesen | |
| UNIDOC HEALTH | 0,160 | +1,91 % | UniDoc Health Corp. kündigt Teilnahme an der Ukraine Recovery Conference (URC2025) an | - UniDoc wird auf der internationalen Veranstaltung in Rom (Italien) seine laufenden humanitären und innovativen Bemühungen im Gesundheitswesen
präsentieren
VANCOUVER,... ► Artikel lesen | |
| ZIMMER BIOMET | 79,98 | -0,27 % | Zimmer Biomet kauft Robotik-Spezialisten Monogram für 177 Millionen Dollar | Der Medizintechnik-Konzern Zimmer Biomet stärkt sein Geschäft mit orthopädischer Robotik: Das Unternehmen übernimmt Monogram Technologies für rund 177 Millionen US-Dollar. Wie beide Firmen am Montag... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results | Revenues increased 9% in Q4 2025 compared to Q4 2024, and 12% in FY 2025 compared to FY 2024Net loss improved 27% in Q4 2025 compared to Q4 2024, and 29% in FY 2025 compared to FY 2024EBITDA loss improved... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,244 | +1,67 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| VERU | 0,522 | +1,16 % | Veru Inc.: Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation | --During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study... ► Artikel lesen | |
| CYTOSORBENTS | 0,921 | +4,42 % | Cytosorbents Corp: CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR | PRINCETON, N.J., July 2, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China | Builds on clearances already received by FDA and EMAChina has the largest population of patients with hepatocellular carcinoma in the world BRISBANE, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Tempest... ► Artikel lesen |
Das Unternehmen CATHETER PRECISION INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,240 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CATHETER PRECISION INC finden Sie auf Wallstreet Online.